Bollard Group LLC - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 90 filers reported holding SPERO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bollard Group LLC ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$19,000
-45.7%
2,2150.0%0.00%0.0%
Q4 2021$35,000
-14.6%
2,2150.0%0.00%0.0%
Q3 2021$41,000
+32.3%
2,2150.0%0.00%0.0%
Q2 2021$31,000
-6.1%
2,2150.0%0.00%0.0%
Q1 2021$33,000
-23.3%
2,2150.0%0.00%
-50.0%
Q4 2020$43,000
+72.0%
2,2150.0%0.00%
+100.0%
Q3 2020$25,000
-16.7%
2,2150.0%0.00%0.0%
Q2 2020$30,0002,2150.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,829,209$53,456,00013.89%
Atlas Venture Associates IX, LLC 1,376,968$19,223,0003.38%
BVF INC/IL 2,137,978$29,846,0001.12%
AWM Investment Company, Inc. 372,755$5,204,0000.51%
Novo Holdings A/S 468,902$6,546,0000.29%
Rock Springs Capital Management LP 965,928$13,484,0000.27%
Alphabet Inc. 889,979$12,424,0000.25%
Artal Group S.A. 500,000$6,980,0000.14%
Granahan Investment Management 332,639$4,644,0000.09%
Radnor Capital Management, LLC 10,000$140,0000.05%
View complete list of SPERO THERAPEUTICS INC shareholders